Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
医学
卵巢癌
肿瘤科
内科学
妇科
癌症
作者
Giorgio Valabrega,Bhavana Pothuri,Ana Oaknin,Whitney S. Graybill,Ana Beatriz Sánchez,Colleen McCormick,Jean‐François Baurain,Anna V. Tinker,Hannelore Denys,Roisin E. O’Cearbhaill,Sakari Hietanen,Richard G. Moore,Anja Ør Knudsen,Thibault de La Motte Rouge,Florian Heitz,Tally Levy,Whitney York,Divya Gupta,Bradley J. Monk,Antonio González‐Martín
To evaluate the impact of age on the efficacy and safety of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer with a complete/partial response to first-line platinum-based chemotherapy.
cdercder
pluto
归尘
Rye227
冰魂
昏睡的蟠桃
bc
jenningseastera
乐乐
ss
平常的毛豆
back you up
科研小民工
遇上就这样吧
不倦
顺心香菇
zmnzmnzmn
Auston_zhong
wy.he
Cat
皖公网安备34019202002308
